Assignee
KINIKSA PHARMACEUTICALS GMBH
CH·2 granted patents·6 pending applications·1 citations·filing 2022–2025
Top patents by PatentIndex Score
8 records- 0181US2026076903A1Formulations of anti-interleukin 1 receptor 1 antibodiesKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0280US12502352B1Formulations of anti-interleukin 1 receptor 1 antibodiesKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Granted Dec 23, 2025·0 cites·29 claims
- 0379US12234294B2Pharmaceutical composition of a humanized anti-CD40 antibodyKINIKSA PHARMACEUTICALS GMBH·Filed 2022·Granted Feb 25, 2025·1 cites·8 claims
- 0475US2026015427A1Formulations of anti-interleukin 1 receptor 1 antibodiesKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0569US2025388686A1Compositions of il-1r1 antibodies and methods of producing and using the sameKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0668US2026022180A1Compositions of il-1r1 antibodies and methods of producing and using the sameKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0756US2025282884A1Pharmaceutical compositions of humanized anti-cd40 antibodiesKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
- 0833US2026022185A1Method of reducing aggregation in the virus-inactivated preparation of anti-cd40 antibodiesKINIKSA PHARMACEUTICALS GMBH·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KINIKSA PHARMACEUTICALS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →